McDermott Will & Emery’s FCA Update blog offers insights into recent developments in False Claims Act (FCA) litigation, enforcement and compliance, and also offers our observations regarding this evolving area of the law.
McDermott’s FCA defense practice is composed of former federal prosecutors and lawyers who are experienced in defending clients against FCA investigations and qui tam (or “whistleblower”) litigation in courts across the US. Our lawyers have successfully defended numerous healthcare, pharmaceutical and medical device companies and their executives against a broad range of claims under the FCA and criminal statutes.
We have substantial experience obtaining declinations, negotiating favorable resolutions with the Department of Justice, state attorneys general, and the Office of the Inspector General, as well as obtaining successful in-court results in FCA cases that proceed to litigation. In addition to representing clients in investigations and litigation, our lawyers regularly advise clients in connection with developing and improving internal mechanisms to enhance compliance and minimize FCA risk.
If you have questions or topic suggestions, please let us know via the Contact form, or reach out to one of our editors directly.
- We’ve Moved!
- More Than a Decade at the Top; McDermott Earns 11th Chambers USA Band 1 Healthcare Practice National Ranking
- New Guidance on Medicare Payment Rule Enforcement
- Stark Law Proposed Change Affects Group Practice Special Rules for Productivity Bonuses, Profit Shares
- Agenda is Live: McDermott’s Healthcare Litigation, Compliance & Investigations Forum